NPI: 1528463080 · KANSAS CITY, MO 64114 · General Acute Care Hospital · NPI assigned 10/27/2014
Authorized official DOAN, CHRISTOPHER controls 20+ related entities in our dataset. Read more
| Authorized Official | DOAN, CHRISTOPHER (MANAGING ASSOCIATE GENERAL COUNSEL) |
| NPI Enumeration Date | 10/27/2014 |
Other providers sharing the same authorized official: DOAN, CHRISTOPHER
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 3,240 | $909K |
| 2019 | 3,755 | $801K |
| 2020 | 3,448 | $419K |
| 2021 | 2,735 | $103K |
| 2022 | 15,467 | $697K |
| 2023 | 21,580 | $1.13M |
| 2024 | 5,073 | $386K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4,882 | 3,941 | $1.06M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 3,979 | 3,436 | $671K |
| X4011 | State-specific procedure code | 1,561 | 1,314 | $511K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 4,050 | 3,585 | $490K |
| X4014 | 1,708 | 1,324 | $440K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 9,285 | 7,608 | $382K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,165 | 1,869 | $160K |
| 80053 | Comprehensive metabolic panel | 5,048 | 4,013 | $149K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1,399 | 1,112 | $120K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3,196 | 2,419 | $97K |
| 71045 | Radiologic examination, chest; single view | 2,066 | 1,610 | $71K |
| 81025 | 348 | 310 | $40K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,205 | 921 | $40K |
| 84484 | 1,363 | 918 | $24K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1,056 | 764 | $24K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1,507 | 1,149 | $16K |
| 96361 | Intravenous infusion, hydration; each additional hour | 466 | 356 | $13K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,102 | 458 | $12K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 532 | 412 | $12K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1,139 | 841 | $12K |
| X4003 | 51 | 45 | $12K | |
| 81003 | 285 | 238 | $11K | |
| 36415 | Collection of venous blood by venipuncture | 3,386 | 2,452 | $9K |
| 83690 | 1,124 | 861 | $9K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 267 | 197 | $9K |
| 80076 | 79 | 71 | $7K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 148 | 118 | $7K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 213 | 151 | $6K |
| 70450 | Computed tomography, head or brain; without contrast material | 109 | 92 | $5K |
| 83605 | 12 | 12 | $5K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 160 | 116 | $4K |
| 81001 | 714 | 583 | $4K | |
| 85027 | 17 | 16 | $3K | |
| J3490 | Unclassified drugs | 193 | 149 | $909.15 |
| 87634 | 14 | 12 | $703.11 | |
| 85610 | 196 | 150 | $302.88 | |
| 85730 | 129 | 100 | $295.58 | |
| 83880 | 16 | 14 | $223.28 | |
| 82550 | 93 | 72 | $215.14 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 19 | 16 | $94.96 |
| 82962 | 16 | 12 | $88.11 |